Danaher Corp (DHER34)

B3
Currency in BRL
38.44
+0.06(+0.16%)
Closed·
DHER34 Scorecard
Full Analysis
Management has been aggressively buying back shares
DHER34 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
38.3838.50
52 wk Range
36.2757.33
Key Statistics
Edit
Bid/Ask
36.90 / 40.74
Prev. Close
38.38
Open
38.38
Day's Range
38.38-38.5
52 wk Range
36.27-57.33
Volume
159
Average Volume (3m)
8.84K
1-Year Change
-20.44%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DHER34 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Danaher Corp News & Analysis

Show more

Danaher Corp BDR Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment offers bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. Its Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services in the areas of clinical chemistry, immunoassay, hematology, and microbiology for hospitals, physicians’ offices, reference laboratories, and other critical care settings. The company has a partnership with AstraZeneca PLC to develop and commercialize diagnostic tools and tests. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District Of Columbia.

Employees
62000
Market
Brazil

Compare DHER34 to Peers and Sector

Metrics to compare
DHER34
Peers
Sector
Relationship
P/E Ratio
37.3x5.8x−0.5x
PEG Ratio
−2.970.090.00
Price/Book
2.8x1.4x2.6x
Price / LTM Sales
5.9x4.5x3.0x
Upside (Analyst Target)
-33.6%52.6%
Fair Value Upside
Unlock20.0%8.8%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 5.19%
Dividend Yield
0.46%
Industry Median 0.59%
Annualised payout
0.18
Paid quarterly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 22, 2025
EPS / Forecast
1.32 / --
Revenue / Forecast
5.74B / --
EPS Revisions
Last 90 days

DHER34 Income Statement

FAQ

What Is the Danaher Corp BDR (DHER34) Stock Price Today?

The Danaher Corp BDR stock price today is 38.44.

What Stock Exchange Does Danaher Corp BDR Trade On?

Danaher Corp BDR is listed and trades on the B3 Stock Exchange stock exchange.

What Is the Stock Symbol for Danaher Corp BDR?

The stock symbol for Danaher Corp BDR is "DHER34."

Does Danaher Corp BDR Pay Dividends? What’s The Current Dividend Yield?

The Danaher Corp BDR dividend yield is 0.46%.

What Is the Danaher Corp BDR Market Cap?

As of today, Danaher Corp BDR market cap is 774.88B.

What Is Danaher Corp BDR's Earnings Per Share (TTM)?

The Danaher Corp BDR EPS (TTM) is 5.19.

From a Technical Analysis Perspective, Is DHER34 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Danaher Corp BDR Stock Split?

Danaher Corp BDR has split 2 times.

How Many Employees Does Danaher Corp BDR Have?

Danaher Corp BDR has 62000 employees.

What is the current trading status of Danaher Corp BDR (DHER34)?

As of 21 Jun 2025, Danaher Corp BDR (DHER34) is trading at a price of 38.44, with a previous close of 38.38. The stock has fluctuated within a day range of 38.38 to 38.50, while its 52-week range spans from 36.27 to 57.33.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.